<DOC>
	<DOCNO>NCT01848899</DOCNO>
	<brief_summary>The aim study determine two different type iodinate contrast medium ( CM ) agent , low-osmolar ionic ioxaglate iso-osmolar non-ionic iodixanol , affect specific marker thrombogenesis platelet function patient undergoing coronary angiography , use bivalirudin , direct thrombin inhibitor use percutaneous coronary intervention ( PCI ) , affect contrast-related change thrombogenesis platelet function .</brief_summary>
	<brief_title>Effects Contrast Platelet Activity , Thrombosis Fibrinolysis Patients Undergoing Coronary Angiography</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Bivalirudin</mesh_term>
	<criteria>Patients must 18 year age refer coronary angiography dual antiplatelet therapy ( aspirin clopidogrel ) . warfarin low molecular weight heparin within 12 hour coronary angiography unfractionated heparin activate clotting time &gt; 150 time procedure cilostazol persantine non steroidal antiinflammatory medication ( ibuprofen/motrin/advil , naproxen/aleve , indomethacin , sulindac , etodolac , diclofenac , celecoxib ) within 72 hour procedure prasugrel ( exclusion criterion STsegment elevation myocardial infarction registry undergo coronary angiography via radial access undergo plan diagnostic coronary angiography unable tolerate dual antiplatelet therapy know allergy CM receive CM within 24 hour coronary angiography dialysis consent unable give consent participate another compete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Coronary angiography</keyword>
	<keyword>Percutaneous coronary intervention</keyword>
	<keyword>Contrast medium</keyword>
	<keyword>Platelet activity</keyword>
	<keyword>Thrombin generation</keyword>
	<keyword>Fibrinolysis</keyword>
</DOC>